Lipocine LPCN
NASDAQ LPCN
$2.05 -0.02 (-0.97%)
At close: Oct 2, 2026 · 4:00 PM EDT

Lipocine (LPCN) Cash from Investing Activities (2013 - 2025)

Updated

Lipocine (LPCN) recorded Cash from Investing Activities of $701,449 in Q3 2025, down 31.4% from $1.02 million a year earlier and down 84.4% from the prior quarter.

Analysis

Lipocine (LPCN) Cash from Investing Activities (2013 - 2025) Analysis & Trends

On a TTM basis, Lipocine's Cash from Investing Activities came in at $5.08 million as of Sep 30, 2025, up 15.2% year-over-year; for FY2024, it was $2.45 million, down 81.3% from FY2023.

  • Annual Cash from Investing Activities has a five-year compound annual growth rate of -4.0% (FY2019 to FY2024).
  • Across earlier years, Cash from Investing Activities came in at $13.08 million in FY2023 (-8.5%), $14.29 million in FY2022, -$43.78 million in FY2021 and $3.89 million in FY2020 (+29.8%).
  • Quarterly Cash from Investing Activities has ranged from -$33.99 million in Q1 2021 to $7.3 million in Q1 2022 over the past five years.
  • On a year-over-year basis, Cash from Investing Activities rose in two of the last six quarters, with an average decline of 14.7%.
  • Peak year-over-year performance for Cash from Investing Activities in the last five years was growth of 870.2% in Q4 2020, against a decline of 72.1% in Q4 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at $4.5 million (Q2 2025), -$882,073 (Q1 2025) and $761,058 (Q4 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -15.40 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -1.11 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -1.20 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -5.60 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.11 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -2.91 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -569.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -10.35 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.11 Bn
10 Lipocine 11.11 Mn -56.60 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 701,449.00
Jun 30, 2025 4.50 Mn
Mar 31, 2025 -882,073.00
Dec 31, 2024 761,058.00
Sep 30, 2024 1.02 Mn
Jun 30, 2024 4.75 Mn
Mar 31, 2024 -4.09 Mn
Dec 31, 2023 2.73 Mn
Sep 30, 2023 1.24 Mn
Jun 30, 2023 3.56 Mn
Mar 31, 2023 5.55 Mn
Dec 31, 2022 2.60 Mn
Sep 30, 2022 613,897.00
Jun 30, 2022 3.79 Mn
Mar 31, 2022 7.30 Mn
Dec 31, 2021 -9.72 Mn
Sep 30, 2021 1.37 Mn
Jun 30, 2021 -1.43 Mn
Mar 31, 2021 -33.99 Mn
Dec 31, 2020 5.41 Mn
API Access

Lipocine Cash from Investing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=LPCN&period=max&api_key=YOUR_API_KEY